| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/08/2006 | CN1742922A Chinese herbal medicine decoction for treating urinary stone of damp-heat stagnation type and preparing method thereof |
| 03/08/2006 | CN1742913A Medicine for treating chronic kidney function deficiency and preparation method |
| 03/08/2006 | CN1742904A Chinese medicine for treating urinary stone and urinary system inflammation, and production method thereof |
| 03/08/2006 | CN1742903A Medicine for treating prostatitis and hyperlasia of prostate |
| 03/08/2006 | CN1742873A Chinese herbal medicine decoction for treating urinary stone of spleen-kidney deficiency type |
| 03/08/2006 | CN1742819A Medicine for preventing and treating diabets and kidney disease and preparing method |
| 03/08/2006 | CN1742813A Soft capsule for treating acute and chronic pyelonephritis and prostatitis and preparing method |
| 03/08/2006 | CN1742744A Compound licorice acid monoamine powder injecta and preparing method |
| 03/08/2006 | CN1742736A Buckthorn extract, its preparing method and use in pharmaceutical process |
| 03/08/2006 | CN1742731A Pyrazole-di-pyridineones for treating female sexual dysfunction |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008940 1,6,7,8-tetrahydro-2,2,4,5-tetramethyl-1-(4-methylphenyl)-2H-furo[3,2-e]indole for example; inhibiting lipoperoxide production (antioxidant); treating restenosis after percutaneous transluminal coronary angioplasty; Alzheimer's disease |
| 03/07/2006 | US7008939 Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008637 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | US20060047007 Method for treating urinary disorders |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577084A1 Bicyclononene derivatives as renin inhibitors |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1629853A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 03/01/2006 | EP1629843A2 Reboxetine for treating chronic fatigue syndrome |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628682A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0842923B1 Pyrrole derivatives and medicinal composition |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741796A Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders |
| 03/01/2006 | CN1739778A Prostate proliferation treating medicine composition |
| 03/01/2006 | CN1739718A Kidney invigorating yurong oral liquid and its prepn |
| 03/01/2006 | CN1739714A Chinese medicine prepn of invigorating kidney and benefiting vital energy and its prepn process and quality control method |
| 03/01/2006 | CN1739713A Prostatosis treating Chinese medicine prepn and its prepn process |
| 03/01/2006 | CN1739696A Prostatitis treating Chinese medicine |
| 03/01/2006 | CN1739679A Medicine for treating nephrolithiasis and its prepn |
| 03/01/2006 | CN1739633A Chinese medicine for treating chronic prostatosis |
| 03/01/2006 | CN1739560A Dietotherapeutic product for preventing and treating urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739558A Dietotherapeutic product for preventing and treating primary and secondary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739557A Dietotherapeutic product for preventing and treating primary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739554A Dietotherapeutic nutrient for preventing and treating secondary urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739553A Dietotherapeutic nutrient for preventing and treating urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739552A Dietotherapeutic nutrient for treating primary and secondary urate calculi acid gout and its prepn process |
| 03/01/2006 | CN1739551A Dietotherapeutic nutrient for treating primary urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739521A Application of pyrimidone compounds in preparing medicine |
| 03/01/2006 | CN1739517A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243734C Pharmaceutical use of Bafuluomaidi |
| 03/01/2006 | CN1243568C Recombination protein for preventing human trachoma bedsnia infestation and its use |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 02/28/2006 | US7005449 Tolterodine salts |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005431 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/23/2006 | WO2006018815A1 Piperazine derivatives as adrenergic receptor antagonists |
| 02/23/2006 | WO2005102319A3 Use of melatonin in preventing postoperative complications |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060040970 Administering 4,5 alpha -epoxy-6 beta -(3,4-dihydro-2H-benzo[1,4]thiazino)-3-methoxy-17-methyl-morphinan; for urinary frequency, therapeutic or prophylactic effect and of which side effects are improved |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040960 (3-amino-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-2-yl)-(2,5-dimethoxyphenyl)methanone; antiproliferative agent; solid tumors: breast, respiratory tract, brain, reproductive organs, digestive tract, liver, skin, head and neck, thyroid, and their metastases; lymphomas, sarcomas, and leukemias |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | DE102004039065A1 New N-substituted 1-benzyl-1H-(1,2,3)-triazole-4-carboxamides, are dopamine and alpha-1 adrenergic receptor ligands useful for treating diseases of the urinary tract, vascular system or CNS |
| 02/23/2006 | CA2577654A1 Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder |
| 02/23/2006 | CA2575155A1 Use of vitamin ds to treat kidney disease |
| 02/23/2006 | CA2575153A1 Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease |
| 02/22/2006 | EP1627888A1 Antibody and use thereof |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1627638A1 Fortifier |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1626957A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 02/22/2006 | EP1626705A1 Low sodium solution |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385856B1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |